Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | AMGN | BMY | GILD | VRTX |
| Company | Celgene Corp | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 108.01 | 263.11 | 57.25 | 92.62 | 391.87 |
| High | 108.59 | 264.80 | 57.61 | 93.22 | 401.71 |
| Low | 107.27 | 260.87 | 56.80 | 91.79 | 390.92 |
| Last | 108.24 | 262.65 | 57.61 | 93.14 | 401.18 |
| Change | +0.11 | -0.73 | +0.28 | +0.57 | +3.91 |
| % Change | +0.10% | -0.28% | +0.49% | +0.62% | +0.98% |
| Volume | 191,230,496 | 1,148,514 | 3,281,909 | 1,775,248 | 899,495 |
| 20-Day Average Volume | 16,188,930 | 5,063,435 | 11,599,225 | 7,448,665 | 1,801,364 |
| Previous Close | 108.13 | 263.38 | 57.33 | 92.57 | 397.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 273.44 | 57.92 | 92.12 | 454.45 |
| 20-Day Raw Stochastic | 63.25% | 22.14% | 44.41% | 72.18% | 23.19% |
| 20-Day Relative Strength | 64.69% | 32.10% | 53.29% | 56.34% | 30.83% |
| Weighted Alpha | +46.30 | -15.24 | +19.89 | +24.56 | -10.20 |
| Today's Opinion | 100% Buy | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 100% Buy | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 100% Buy | 40% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | -1.30% since 12/16/24 | +3.00% since 12/16/24 | +1.16% since 12/16/24 | -14.39% since 12/16/24 |
| Low | 107.27 on 11/20/19 | 253.30 on 12/19/24 | 56.05 on 12/17/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 110.53 on 11/14/19 | 270.26 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 | 474.18 on 12/17/24 |
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | -10.69% since 11/22/24 | -2.25% since 11/22/24 | +3.25% since 11/22/24 | -11.14% since 11/22/24 |
| Low | 102.40 on 10/21/19 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 110.70 on 11/13/19 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | -21.62% since 09/23/24 | +15.07% since 09/23/24 | +10.87% since 09/23/24 | -12.89% since 09/23/24 |
| Low | 93.41 on 08/23/19 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 110.70 on 11/13/19 | 335.41 on 09/24/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | -14.64% since 06/21/24 | +37.24% since 06/21/24 | +31.77% since 06/21/24 | -14.51% since 06/21/24 |
| Low | 89.08 on 07/23/19 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 110.70 on 11/13/19 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 141,575,456 | 116,275,392 | 115,366,840 | 102,308,544 |
| Shares Outstanding, K | 711,714 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 15,281,000,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 4,046,000,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 4,520,000,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | 1,691,000,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 1.41 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 10/31/19 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 13.70 | 49.00 | 20.90 | 0.00 |